BBK Capital Partners »

Takeda Pharmaceutical shares owned by BBK Capital Partners

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by BBK Capital Partners from 13F filings

Historical chart of BBK Capital Partners investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by BBK Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $195k 14k 14.27

More positions owned by BBK Capital Partners

Procter & Gamble Company (PG)
Apple (AAPL)
Etf Opportunities Trust Formidable Etf (FORH)
Etf Opportunities Trust Formidable Fortr (KONG)
Chevron Corporation (CVX)
Chemed Corp Com Stk (CHE)
Flux Pwr Hldgs (FLUX)
Microsoft Corporation (MSFT)
Eaton Vance Tax-Managed Global Dive Eq (EXG)
Meta Platforms Cl A (META)
Gamco Global Gold Nat Res & Com Sh Ben Int (GGN)
Acacia Resh Corp Acacia Tch Com (ACTG)
NVIDIA Corporation (NVDA)
Ishares Tr Core High Dv Etf (HDV)
Eaton V.Tax-Advantaged Dividend Inc Fund (EVT)

View all positions for BBK Capital Partners

Top funds holding Takeda Pharmaceutical

Millennium Management
Goldman Sachs Group
Brandes Investment Partners
Arrowstreet Capital, Limited Partnership
Polygon Management
Managed Asset Portfolios
Van Eck Associates Corp.
Causeway Capital Management
Y.D. More Investments
Jane Street
Citadel Advisors
Bank of America Corporation
Wells Fargo & Company
Natixis Asset Management Advisors
Nomura Holdings

View all funds holding Takeda Pharmaceutical